![]() ![]() That has led to huge potential payouts - some already realized, according to a Kaiser Health News (KHN) analysis of SEC filings and other government documents. The Trump administration relied on an unusual maneuver that allowed executives to keep investments in drug companies that would benefit from the government’s pandemic efforts: They were brought on as contractors, doing an end run around federal conflict-of-interest regulations in place for employees. In his Rose Garden speech on May 15, Trump lauded Slaoui as “one of the most respected men in the world” on vaccines. It wouldn’t be long before President Donald Trump announced Slaoui as the top scientific adviser for the government’s $12 billion Operation Warp Speed program to rush COVID vaccines to market. The award added to 137,168 options he’d accumulated since 2018, the filings show. Securities and Exchange Commission (SEC) filings. Thirteen days after the massive infusion of federal cash - which triggered a jump in the company’s stock price - Moncef Slaoui, a Moderna board member and longtime drug industry executive, was awarded options to buy 18,270 shares in the company, according to U.S. It had received roughly half a billion dollars in federal funding to develop a COVID shot that might be used on millions of Americans. government’s race for a coronavirus vaccine. It's free.Īpril 16 was a big day for Moderna, a Massachusetts biotech company on the verge of becoming a frontrunner in the U.S. Subscribe to The Defender's Top News of the Day. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |